CN107002140A - 通过合成探针的纳米孔隙探测的靶序列检测 - Google Patents
通过合成探针的纳米孔隙探测的靶序列检测 Download PDFInfo
- Publication number
- CN107002140A CN107002140A CN201580064356.4A CN201580064356A CN107002140A CN 107002140 A CN107002140 A CN 107002140A CN 201580064356 A CN201580064356 A CN 201580064356A CN 107002140 A CN107002140 A CN 107002140A
- Authority
- CN
- China
- Prior art keywords
- probe
- nanoaperture
- nanometers
- polynucleotides
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 99
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 99
- 239000002157 polynucleotide Substances 0.000 claims abstract description 99
- 238000000034 method Methods 0.000 claims abstract description 86
- 238000001514 detection method Methods 0.000 claims abstract description 64
- 239000000523 sample Substances 0.000 claims description 372
- 108020004414 DNA Proteins 0.000 claims description 174
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 105
- 102000053602 DNA Human genes 0.000 claims description 34
- 230000004048 modification Effects 0.000 claims description 26
- 238000012986 modification Methods 0.000 claims description 26
- 239000011148 porous material Substances 0.000 claims description 26
- 230000033001 locomotion Effects 0.000 claims description 25
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 230000008859 change Effects 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 21
- 230000027455 binding Effects 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 150000007523 nucleic acids Chemical class 0.000 claims description 17
- 102000039446 nucleic acids Human genes 0.000 claims description 17
- 108020004707 nucleic acids Proteins 0.000 claims description 17
- 238000005259 measurement Methods 0.000 claims description 14
- 230000009977 dual effect Effects 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 229920002477 rna polymer Polymers 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 230000000295 complement effect Effects 0.000 claims description 8
- 230000004927 fusion Effects 0.000 claims description 8
- 238000007385 chemical modification Methods 0.000 claims description 7
- 230000003993 interaction Effects 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 7
- 230000009286 beneficial effect Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 6
- 108091033409 CRISPR Proteins 0.000 claims description 5
- 238000010354 CRISPR gene editing Methods 0.000 claims description 5
- 238000010459 TALEN Methods 0.000 claims description 5
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 5
- 239000002777 nucleoside Substances 0.000 claims description 5
- 125000003835 nucleoside group Chemical group 0.000 claims description 5
- 230000009870 specific binding Effects 0.000 claims description 4
- 241000218636 Thuja Species 0.000 claims description 3
- 230000021736 acetylation Effects 0.000 claims description 3
- 238000006640 acetylation reaction Methods 0.000 claims description 3
- 230000006287 biotinylation Effects 0.000 claims description 3
- 238000007413 biotinylation Methods 0.000 claims description 3
- 230000013595 glycosylation Effects 0.000 claims description 3
- 238000006206 glycosylation reaction Methods 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 230000026731 phosphorylation Effects 0.000 claims description 3
- 238000006366 phosphorylation reaction Methods 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- 108091005573 modified proteins Proteins 0.000 claims description 2
- 102000035118 modified proteins Human genes 0.000 claims description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 claims 1
- 238000000151 deposition Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 13
- 229920001223 polyethylene glycol Polymers 0.000 description 73
- 239000002202 Polyethylene glycol Substances 0.000 description 39
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 30
- 108010087904 neutravidin Proteins 0.000 description 24
- 238000002474 experimental method Methods 0.000 description 20
- 241000209094 Oryza Species 0.000 description 19
- 235000007164 Oryza sativa Nutrition 0.000 description 19
- 235000009566 rice Nutrition 0.000 description 19
- 241000894006 Bacteria Species 0.000 description 16
- 235000020958 biotin Nutrition 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 16
- 239000002585 base Substances 0.000 description 15
- 229960002685 biotin Drugs 0.000 description 15
- 239000011616 biotin Substances 0.000 description 15
- 238000010586 diagram Methods 0.000 description 15
- 238000003556 assay Methods 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 238000006073 displacement reaction Methods 0.000 description 11
- 241000894007 species Species 0.000 description 10
- 241001134658 Streptococcus mitis Species 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 101150029409 CFTR gene Proteins 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 229910052581 Si3N4 Inorganic materials 0.000 description 7
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 7
- -1 sulphonic acid ester Chemical class 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 6
- 229910021389 graphene Inorganic materials 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 238000000295 emission spectrum Methods 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- 201000003883 Cystic fibrosis Diseases 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010064571 Gene mutation Diseases 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 230000002860 competitive effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005553 drilling Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 150000007857 hydrazones Chemical class 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 150000003141 primary amines Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 108091006146 Channels Proteins 0.000 description 2
- 230000004568 DNA-binding Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010022355 Fibroins Proteins 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 108090000848 Ubiquitin Proteins 0.000 description 2
- 102000044159 Ubiquitin Human genes 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical class OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 108010040974 cystic fibrosis transmembrane conductance regulator delta F508 Proteins 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- HRKQOINLCJTGBK-UHFFFAOYSA-N dihydroxidosulfur Chemical compound OSO HRKQOINLCJTGBK-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000000695 excitation spectrum Methods 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000006384 oligomerization reaction Methods 0.000 description 2
- 230000006320 pegylation Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- DZWJBKUVHJSHAR-UHFFFAOYSA-M trimethyl(2-methylsulfonylsulfanylethyl)azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCSS(C)(=O)=O DZWJBKUVHJSHAR-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- LLYXJBROWQDVMI-UHFFFAOYSA-N 2-chloro-4-nitrotoluene Chemical compound CC1=CC=C([N+]([O-])=O)C=C1Cl LLYXJBROWQDVMI-UHFFFAOYSA-N 0.000 description 1
- HKERMLQDWIEJQS-UHFFFAOYSA-N 2-methylsulfonothioyloxyethanamine Chemical class CS(=O)(=S)OCCN HKERMLQDWIEJQS-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108010023798 Charybdotoxin Proteins 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 101000945318 Homo sapiens Calponin-1 Proteins 0.000 description 1
- 101000652736 Homo sapiens Transgelin Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102100031013 Transgelin Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 230000000454 anti-cipatory effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000000225 bioluminescence resonance energy transfer Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- CNVQLPPZGABUCM-LIGYZCPXSA-N ctx toxin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]3CSSC[C@@H](C(N[C@@H](CC=4C5=CC=CC=C5NC=4)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC3=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CO)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3NC=NC=3)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N2)C(C)C)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC1=O)=O)CCSC)C(C)C)[C@@H](C)O)NC(=O)[C@H]1NC(=O)CC1)C1=CC=CC=C1 CNVQLPPZGABUCM-LIGYZCPXSA-N 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(IV) oxide Inorganic materials O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004047 hole gas Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000010884 ion-beam technique Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 239000002090 nanochannel Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- RDBMUARQWLPMNW-UHFFFAOYSA-N phosphanylmethanol Chemical compound OCP RDBMUARQWLPMNW-UHFFFAOYSA-N 0.000 description 1
- 238000004647 photon scanning tunneling microscopy Methods 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000002165 resonance energy transfer Methods 0.000 description 1
- 108091008020 response regulators Proteins 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/107—Modifications characterised by incorporating a peptide nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/164—Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/60—Detection means characterised by use of a special device
- C12Q2565/607—Detection means characterised by use of a special device being a sensor, e.g. electrode
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/60—Detection means characterised by use of a special device
- C12Q2565/631—Detection means characterised by use of a special device being a biochannel or pore
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Abstract
Description
反应性基团 | 目标功能基团 |
芳基叠氮化物 | 非选择性或伯胺 |
碳二亚胺 | 胺/羧基 |
酰肼 | 碳水化合物 |
羟甲基膦 | 胺 |
亚氨酸酯 | 胺 |
异氰酸酯 | 羟基 |
羰基 | 肼 |
马来酰亚胺 | 巯基 |
NHS-酯 | 胺 |
PFP-酯 | 胺 |
补骨脂素 | 胸腺嘧啶 |
吡啶二硫化物 | 巯基 |
乙烯基砜 | 巯基胺,羟基 |
Claims (39)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462056378P | 2014-09-26 | 2014-09-26 | |
US62/056,378 | 2014-09-26 | ||
PCT/US2015/052729 WO2016049657A1 (en) | 2014-09-26 | 2015-09-28 | Target sequence detection by nanopore sensing of synthetic probes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107002140A true CN107002140A (zh) | 2017-08-01 |
Family
ID=55582170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201580064356.4A Pending CN107002140A (zh) | 2014-09-26 | 2015-09-28 | 通过合成探针的纳米孔隙探测的靶序列检测 |
Country Status (11)
Country | Link |
---|---|
US (2) | US20170349940A1 (zh) |
EP (1) | EP3198036A4 (zh) |
JP (1) | JP6702951B2 (zh) |
KR (1) | KR20170064540A (zh) |
CN (1) | CN107002140A (zh) |
AU (2) | AU2015319825A1 (zh) |
CA (1) | CA2962234A1 (zh) |
IL (1) | IL251274A0 (zh) |
MX (1) | MX2017003790A (zh) |
RU (1) | RU2681822C2 (zh) |
WO (1) | WO2016049657A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110488013A (zh) * | 2019-07-26 | 2019-11-22 | 东南大学 | 结合纳米孔技术的肿瘤标志miRNA检测装置及方法 |
CN111778244A (zh) * | 2020-05-29 | 2020-10-16 | 南京邮电大学 | 一种结合金纳米球的DNA探针及其在基于固态纳米孔检测Hg2+中的应用 |
CN112795628A (zh) * | 2021-02-05 | 2021-05-14 | 南京邮电大学 | 基于固态纳米孔传感器的miRNA检测方法、检测探针及试剂盒 |
CN114487045A (zh) * | 2022-01-26 | 2022-05-13 | 军事科学院军事医学研究院环境医学与作业医学研究所 | 一种检测T2毒素的CRISPR-Cas14a响应型光电化学传感检测方法和试剂盒 |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US20150351906A1 (en) | 2013-01-24 | 2015-12-10 | Mitraltech Ltd. | Ventricularly-anchored prosthetic valves |
EP2994751B1 (en) | 2013-05-06 | 2018-10-10 | Two Pore Guys, Inc. | A method of biological target detection using a nanopore and a fusion protein binding agent |
KR102245192B1 (ko) * | 2013-05-06 | 2021-04-29 | 온테라 인크. | 나노포어를 이용한 표적 검출 |
US9868979B2 (en) | 2013-06-25 | 2018-01-16 | Prognosys Biosciences, Inc. | Spatially encoded biological assays using a microfluidic device |
KR20240013283A (ko) | 2014-12-03 | 2024-01-30 | 애질런트 테크놀로지스, 인크. | 화학적 변형을 갖는 가이드 rna |
CA2973940C (en) | 2015-02-05 | 2022-08-23 | Mitraltech Ltd. | Prosthetic valve with axially-sliding frames |
KR20240038141A (ko) | 2015-04-06 | 2024-03-22 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna |
ES2955916T3 (es) | 2015-04-10 | 2023-12-11 | Spatial Transcriptomics Ab | Análisis múltiplex de especímenes biológicos de ácidos nucleicos espacialmente distinguidos |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
JP2019509039A (ja) * | 2016-02-25 | 2019-04-04 | クアンタポール, インコーポレイテッド | 移行反転による冗長ポリマー分析 |
US11486873B2 (en) | 2016-03-31 | 2022-11-01 | Ontera Inc. | Multipore determination of fractional abundance of polynucleotide sequences in a sample |
EP3436818A4 (en) * | 2016-03-31 | 2019-11-06 | Ontera Inc. | DIFFERENTIATION, THROUGH NANOPORES, OF TARGET POLYNUCLEOTIDES FROM FRAGMENTATION SAMPLE BACKGROUND AND USEFUL LOAD LINK |
US10767175B2 (en) | 2016-06-08 | 2020-09-08 | Agilent Technologies, Inc. | High specificity genome editing using chemically modified guide RNAs |
US10669579B2 (en) | 2016-07-15 | 2020-06-02 | International Business Machines Corporation | DNA sequencing with stacked nanopores |
WO2018029680A1 (en) | 2016-08-10 | 2018-02-15 | Mitraltech Ltd. | Prosthetic valve with concentric frames |
AU2017348009B2 (en) | 2016-10-24 | 2019-10-10 | Ontera Inc. | Fractional abundance of polynucleotide sequences in a sample |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US11753636B2 (en) | 2017-10-18 | 2023-09-12 | Infusion Tech | Method for enriching pathogen, using homobifunctional imidoester |
US10890560B2 (en) | 2018-05-21 | 2021-01-12 | International Business Machines Corporation | Forming nanoscale pores in a semiconductor structure utilizing nanotubes as a sacrificial template |
EP3844307A1 (en) * | 2018-08-28 | 2021-07-07 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic dna in a biological sample |
US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
CN112969914A (zh) * | 2018-09-07 | 2021-06-15 | 奥特拉公司 | 用于使用纳米孔装置检测分子的感测组合物、方法和装置 |
KR102176130B1 (ko) * | 2018-11-13 | 2020-11-10 | 고려대학교 산학협력단 | 마이크로 포어를 이용한 생체 분자 검출 장치 |
WO2020123301A2 (en) | 2018-12-10 | 2020-06-18 | 10X Genomics, Inc. | Generating spatial arrays with gradients |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
WO2020243579A1 (en) | 2019-05-30 | 2020-12-03 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
KR102233294B1 (ko) | 2019-06-13 | 2021-03-29 | 한국과학기술원 | 표적 dna 검출용 조성물과 이를 이용한 표적 dna의 검출 방법 및 이를 이용한 표적 dna의 정량 방법 |
EP4025711A2 (en) | 2019-11-08 | 2022-07-13 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
SG11202106899SA (en) | 2019-12-23 | 2021-09-29 | 10X Genomics Inc | Methods for spatial analysis using rna-templated ligation |
US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
ES2965354T3 (es) | 2020-04-22 | 2024-04-12 | 10X Genomics Inc | Métodos para análisis espacial que usan eliminación de ARN elegido como diana |
EP4153776A1 (en) | 2020-05-22 | 2023-03-29 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
EP4153775A1 (en) | 2020-05-22 | 2023-03-29 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
WO2021252499A1 (en) | 2020-06-08 | 2021-12-16 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
WO2021252591A1 (en) | 2020-06-10 | 2021-12-16 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
US20210396762A1 (en) * | 2020-06-19 | 2021-12-23 | Encodia, Inc. | Methods for peptide analysis employing multi-component detection agent and related kits |
CN116034166A (zh) | 2020-06-25 | 2023-04-28 | 10X基因组学有限公司 | Dna甲基化的空间分析 |
US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
KR20220069865A (ko) | 2020-11-20 | 2022-05-27 | 한국과학기술원 | 표적 핵산 검출용 조성물 및 이를 이용한 표적 핵산의 검출 방법 |
WO2022140028A1 (en) | 2020-12-21 | 2022-06-30 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
CN114686577A (zh) * | 2020-12-31 | 2022-07-01 | 苏州罗岛纳米科技有限公司 | 一种dna序列检测方法及dna序列检测设备 |
EP4196605A1 (en) | 2021-09-01 | 2023-06-21 | 10X Genomics, Inc. | Methods, compositions, and kits for blocking a capture probe on a spatial array |
KR20240055811A (ko) | 2021-09-10 | 2024-04-29 | 애질런트 테크놀로지스, 인크. | 프라임 편집을 위한 화학적 변형을 갖는 가이드 rna |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030143614A1 (en) * | 1999-03-25 | 2003-07-31 | Drmanac Radoje T. | Solution-based methods and materials for sequence analysis by hybridization |
US20100291548A1 (en) * | 2006-03-12 | 2010-11-18 | Applera Corporation | Methods of Detecting Target Nucleic Acids |
WO2011028494A2 (en) * | 2009-08-24 | 2011-03-10 | Trustees Of Boston University | Label-free sensing of pna-dna complexes using nanopores |
CN103451265A (zh) * | 2012-05-31 | 2013-12-18 | 凯晶生物科技(苏州)有限公司 | 电场作用下用微孔阵列固液相捕获单分子模板dna的方法 |
CN106471369A (zh) * | 2014-05-05 | 2017-03-01 | 双孔人公司 | 利用纳米细孔的目标检测 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5667974A (en) * | 1995-06-07 | 1997-09-16 | Abbott Laboratories | Method for detecting nucleic acid sequences using competitive amplification |
GB9803382D0 (en) * | 1998-02-19 | 1998-04-15 | Secr Defence | Detection system |
US6287772B1 (en) * | 1998-04-29 | 2001-09-11 | Boston Probes, Inc. | Methods, kits and compositions for detecting and quantitating target sequences |
EP1130113A1 (en) * | 2000-02-15 | 2001-09-05 | Johannes Petrus Schouten | Multiplex ligation dependent amplification assay |
US7601497B2 (en) * | 2000-06-15 | 2009-10-13 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
US6451588B1 (en) * | 2000-06-30 | 2002-09-17 | Pe Corporation (Ny) | Multipartite high-affinity nucleic acid probes |
US20030215864A1 (en) * | 2002-04-23 | 2003-11-20 | U.S. Genomics, Inc. | Compositions and methods related to two-arm nucleic acid probes |
GB0223563D0 (en) * | 2002-10-10 | 2002-11-20 | Secr Defence | Detection system |
CA2544476A1 (en) * | 2003-12-12 | 2005-06-23 | Infectio Recherche Inc. | System for charge-based detection of nucleic acids |
US20050136408A1 (en) * | 2003-12-19 | 2005-06-23 | May Tom-Moy | Methods and systems for characterizing a polymer |
CA2577079C (en) * | 2004-08-13 | 2014-05-20 | President And Fellows Of Harvard College | An ultra high-throughput opti-nanopore dna readout platform |
US20060073489A1 (en) * | 2004-10-05 | 2006-04-06 | Gangqiang Li | Nanopore separation devices and methods of using same |
WO2006045009A2 (en) * | 2004-10-20 | 2006-04-27 | Stratagene California | Triplex probe compositions and methods for polynucleotide detection |
EP1688150A1 (en) * | 2005-02-08 | 2006-08-09 | Novo Nordisk A/S | Process for the preparation of alkoxyamine functionalised poly ethylene glycols |
US20070190543A1 (en) * | 2005-11-14 | 2007-08-16 | Applera Corporation | Coded Molecules for Detecting Target Analytes |
GB0605584D0 (en) * | 2006-03-20 | 2006-04-26 | Olink Ab | Method for analyte detection using proximity probes |
CN102083998B (zh) * | 2007-06-19 | 2016-08-03 | 斯特拉托斯基因公司 | 通过展开进行高通量核酸测序 |
US8852864B2 (en) * | 2008-01-17 | 2014-10-07 | Sequenom Inc. | Methods and compositions for the analysis of nucleic acids |
WO2009140666A2 (en) * | 2008-05-15 | 2009-11-19 | Ribomed Biotechnologies, Inc. | METHODS AND REAGENTS FOR DETECTING CpG METHYLATION WITH A METHYL CpG BINDING PROTEIN (MBP) |
US9121823B2 (en) * | 2010-02-19 | 2015-09-01 | The Trustees Of The University Of Pennsylvania | High-resolution analysis devices and related methods |
DK2539355T3 (da) * | 2010-02-26 | 2017-01-02 | Ventana Med Syst Inc | IN-SITU-hybridisering med polytag-prober |
GB201021499D0 (en) * | 2010-12-20 | 2011-02-02 | Loxbridge Res Llp | Detection of quantative genetic differnces |
US8961763B2 (en) * | 2011-07-20 | 2015-02-24 | The Regents Of The University Of California | Dual-pore device |
WO2013056241A2 (en) * | 2011-10-14 | 2013-04-18 | Pacific Biosciences Of California, Inc. | Real-time redox sequencing |
US20140099726A1 (en) * | 2012-10-10 | 2014-04-10 | Two Pore Guys, Inc. | Device for characterizing polymers |
US9605309B2 (en) * | 2012-11-09 | 2017-03-28 | Genia Technologies, Inc. | Nucleic acid sequencing using tags |
EP2994751B1 (en) * | 2013-05-06 | 2018-10-10 | Two Pore Guys, Inc. | A method of biological target detection using a nanopore and a fusion protein binding agent |
EP3014264A4 (en) * | 2013-06-25 | 2016-11-16 | Two Pore Guys Inc | QUANTIFICATION OF MULTIPLEXED BIOMARKERS BY NANOPORENT ANALYSIS OF BIOMARKER POLYMER COMPLEXES |
US9983191B2 (en) * | 2015-03-11 | 2018-05-29 | Two Pore Guys, Inc. | Nanopore detection of small molecules through competition assays |
-
2015
- 2015-09-28 US US15/513,472 patent/US20170349940A1/en not_active Abandoned
- 2015-09-28 EP EP15843316.9A patent/EP3198036A4/en not_active Ceased
- 2015-09-28 CN CN201580064356.4A patent/CN107002140A/zh active Pending
- 2015-09-28 JP JP2017516410A patent/JP6702951B2/ja active Active
- 2015-09-28 AU AU2015319825A patent/AU2015319825A1/en not_active Abandoned
- 2015-09-28 WO PCT/US2015/052729 patent/WO2016049657A1/en active Application Filing
- 2015-09-28 MX MX2017003790A patent/MX2017003790A/es unknown
- 2015-09-28 CA CA2962234A patent/CA2962234A1/en not_active Abandoned
- 2015-09-28 KR KR1020177011263A patent/KR20170064540A/ko not_active Application Discontinuation
- 2015-09-28 RU RU2017114160A patent/RU2681822C2/ru active
-
2017
- 2017-03-19 IL IL251274A patent/IL251274A0/en unknown
-
2022
- 2022-03-11 US US17/693,222 patent/US20220195501A1/en active Pending
- 2022-03-11 AU AU2022201705A patent/AU2022201705A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030143614A1 (en) * | 1999-03-25 | 2003-07-31 | Drmanac Radoje T. | Solution-based methods and materials for sequence analysis by hybridization |
US20100291548A1 (en) * | 2006-03-12 | 2010-11-18 | Applera Corporation | Methods of Detecting Target Nucleic Acids |
WO2011028494A2 (en) * | 2009-08-24 | 2011-03-10 | Trustees Of Boston University | Label-free sensing of pna-dna complexes using nanopores |
CN103451265A (zh) * | 2012-05-31 | 2013-12-18 | 凯晶生物科技(苏州)有限公司 | 电场作用下用微孔阵列固液相捕获单分子模板dna的方法 |
CN106471369A (zh) * | 2014-05-05 | 2017-03-01 | 双孔人公司 | 利用纳米细孔的目标检测 |
Non-Patent Citations (1)
Title |
---|
夏邦顺等: "《临床分子诊断学》", 31 July 2012, 中山大学出版社 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110488013A (zh) * | 2019-07-26 | 2019-11-22 | 东南大学 | 结合纳米孔技术的肿瘤标志miRNA检测装置及方法 |
CN110488013B (zh) * | 2019-07-26 | 2023-02-28 | 东南大学 | 结合纳米孔技术的肿瘤标志miRNA检测装置及方法 |
CN111778244A (zh) * | 2020-05-29 | 2020-10-16 | 南京邮电大学 | 一种结合金纳米球的DNA探针及其在基于固态纳米孔检测Hg2+中的应用 |
CN111778244B (zh) * | 2020-05-29 | 2023-10-27 | 南京邮电大学 | 一种结合金纳米球的DNA探针及其在基于固态纳米孔检测Hg2+中的应用 |
CN112795628A (zh) * | 2021-02-05 | 2021-05-14 | 南京邮电大学 | 基于固态纳米孔传感器的miRNA检测方法、检测探针及试剂盒 |
CN112795628B (zh) * | 2021-02-05 | 2024-02-23 | 南京邮电大学 | 基于固态纳米孔传感器的miRNA检测方法、检测探针及试剂盒 |
CN114487045A (zh) * | 2022-01-26 | 2022-05-13 | 军事科学院军事医学研究院环境医学与作业医学研究所 | 一种检测T2毒素的CRISPR-Cas14a响应型光电化学传感检测方法和试剂盒 |
CN114487045B (zh) * | 2022-01-26 | 2023-05-09 | 军事科学院军事医学研究院环境医学与作业医学研究所 | 一种检测T2毒素的CRISPR-Cas14a响应型光电化学传感检测方法和试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
EP3198036A4 (en) | 2018-08-08 |
IL251274A0 (en) | 2017-05-29 |
RU2017114160A (ru) | 2018-10-26 |
JP6702951B2 (ja) | 2020-06-03 |
KR20170064540A (ko) | 2017-06-09 |
AU2015319825A1 (en) | 2017-04-27 |
AU2022201705A1 (en) | 2022-04-07 |
RU2017114160A3 (zh) | 2018-10-26 |
US20220195501A1 (en) | 2022-06-23 |
US20170349940A1 (en) | 2017-12-07 |
JP2017529089A (ja) | 2017-10-05 |
WO2016049657A1 (en) | 2016-03-31 |
MX2017003790A (es) | 2017-08-07 |
EP3198036A1 (en) | 2017-08-02 |
CA2962234A1 (en) | 2016-03-31 |
RU2681822C2 (ru) | 2019-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107002140A (zh) | 通过合成探针的纳米孔隙探测的靶序列检测 | |
US11685922B2 (en) | Aptamer method | |
US11959135B2 (en) | Coupling method | |
US10495628B2 (en) | Multiplexed biomarker quantitation by nanopore analysis of biomarker-polymer complexes | |
CN104126018B (zh) | 酶方法 | |
KR102245192B1 (ko) | 나노포어를 이용한 표적 검출 | |
CN106471369B (zh) | 利用纳米细孔的目标检测 | |
US20190055592A1 (en) | Nanopore Discrimination of Target Polynucleotides from Sample Background by Fragmentation and Payload Binding | |
CN107109472A (zh) | 利用互相猝灭的荧光标记物的基于纳米孔的聚合物分析 | |
CN116338174A (zh) | 包括使用多核苷酸报道分子和跨膜孔的确定靶分析物的存在或不存在的方法 | |
JP2018537673A (ja) | 追跡及び検出のための標的修飾 | |
US20240158848A1 (en) | Coupling method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1235090 Country of ref document: HK |
|
CB02 | Change of applicant information |
Address after: California, USA Applicant after: ALTELA, Inc. Address before: California, USA Applicant before: TWO PORE GUYS Inc. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211103 Address after: California, USA Applicant after: Norma biology Address before: California, USA Applicant before: ALTELA, Inc. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170801 |
|
RJ01 | Rejection of invention patent application after publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1235090 Country of ref document: HK |